On-Demand Webinars

31. Overcoming Formulation Challenges For mRNA, High-Concentration Proteins

    Increased demand for protein delivery and the emergence of advanced modalities – including mRNA – are introducing new challenges to the development lifecycle, such as high-concentration formulations.

32. From Powder To Particles With Jet Milling

    Gain valuable insights into the jet milling process and Quality by Design approach for inhalation drug delivery and their potential applications in drug development.

33. Key Considerations When Developing Your Combination Product 2/20/2024

    Succeed in combination product development by understanding the risk factors that may arise and implementing mitigation strategies that will streamline the device development process.

34. Survival Kit For Quality Regulations: A Closer Look At Lyo Packaging

    Explore primary packaging developed following well-established ICH principles for sustainable compliance and vial container closure systems for product development and commercial manufacturing needs.

35. Scaling Up A Revolutionary Amorphous Solid Dispersion Platform 3/19/2024

    Process parameter and quality attribute relationships, including those for typical pre- and post-ASD unit operations, will be explored in the context of real-world examples.

36. Rapid, Material-Sparing Feasibility Screening For Hot Melt Extrusion

    Discover a screening process to quickly assess HME feasibility that yields more accurate predictions for API loading and degradation while saving material and time compared to traditional approaches.

37. Challenges Associated With In-Use Simulated Administration Of Biologics

    Explore some of the more challenging aspects surrounding in-use testing for parenteral delivery along with potential strategies to address these issues.

38. Improving Bioavailability, Drug Loads, And Pill Burdens Of Solid Dispersions 9/10/2024

    Explore the pros and cons of marketed amorphous solid dispersions with so-far unpublished data as well as a green alternative to ASDs: best-in-class nanotechnology to manufacture nanocrystals.

39. Strategies For Lipid-Based Drug Delivery Systems And Oral Dosage Forms

    Experts share principles, advantages and disadvantages of different dose forms, and considerations for selecting a suitable dosage form for early phase development programs to commercialization.

40. Dry Powder Inhalable Vaccines For Shelf Stability And Global Access 6/3/2024

    Complex storage requirements can result in limited access to vaccines. But what if a formulation that removed the need for cold chain distribution was possible? Explore the formulation of vaccines with dry powder respiratory delivery in mind and manufacturing considerations for dry powder inhaled vaccines.